The role of HMGB1 is being investigated in the context of possible novel treatments targeting the DAMP in several neurological conditions, such as stroke, subarachnoid hemorrhage, traumatic brain injury, epilepsy and neurodegenerative diseases [82]. The gene discussed is HMGB1; the disease is neurodegenerative disease.